TRYP Therapeutics Inc TRYPF:OTCPK

RT Quote | Exchange | USD
Last | 3:56 PM EST
0.6199quote price arrow down-0.0041 (-0.6571%)
Volume
48,080
52 week range
0.56 - 1.04

...

Loading . . .

KEY STATS

  • Open0.7084
  • Day High0.71
  • Day Low0.6044
  • Prev Close0.624
  • 52 Week High1.04
  • 52 Week High Date02/09/21
  • 52 Week Low0.56
  • 52 Week Low Date03/04/21
  • Market Cap24.54M
  • Shares Out39.29M
  • 10 Day Average Volume63,024.6
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest TRYP Therapeutics Inc News

There is no recent news for this security.

Latest TRYPF News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Tryp Therapeutics Inc. is a Canada-based clinical stage pharmaceutical company. The Company is focused on developing compounds for the treatment of rare or orphan diseases and other diseases with unmet medical needs. Its lead development program, psilocybinfor-neuropsychiatry (PFN) program, is designed to treat neuropsychiatric disorders through the dosing of formulations of synthetic psilocybin. The indication for its PFN program is fibromyalgia. The Company is also...
Address
335 - 1632 Dickson Avenue
Kelowna, BC
V1Y 7T2
Canada